Nickoles Named President at Bayview

Jennifer Nickoles at the Baltimore Convention Center Field Hospital.

Published in Hopkins Medicine - Spring/Summer 2023

Jennifer Nickoles, who has served as interim president of Johns Hopkins Bayview Medical Center since July 2022, was named president in April.

Nickoles, who for three years (2016–2019) was Johns Hopkins Medicine chief of staff for then Dean Paul Rothman,  first came to Johns Hopkins in 1996 as a space management data coordinator in the school of medicine’s facilities management department. 

 She subsequently contributed to the advancement of the school in the Department of Medicine and the office of the vice dean in various management, financial and director roles with progressive responsibility and scope for nearly 20 years. During that time, she also received an advanced degree from Johns Hopkins Carey Business School.

In 2019, Nickoles took on the role of interim vice president of operations for Johns Hopkins All Children’s Hospital, developing and implementing a health system integration plan, co-leading the CMS regulatory improvement process and overseeing support services. She returned to Baltimore at the onset of the COVID-19 pandemic, serving as the chief operating officer of the Baltimore Convention Center Field Hospital. 

She went on to serve as vice president of operations for system integration and affiliations, where she was responsible for further integrating the Johns Hopkins Health System network of hospitals across Maryland, Washington, D.C., and Florida and for leading the Office of Healthcare Transformation and Strategic Planning. In addition, Nickoles has led in the roles of interim vice president and chief operating officer in the Office of Johns Hopkins Physicians while concurrently serving as interim executive director of the Clinical Practice Association for Johns Hopkins Medicine. 

A $35 Million Boost to Study Cancer Metastasis

With a $35 million gift from researcher, philanthropist and race car driver Theodore Giovanis, scientists at Johns Hopkins Medicine will study the biological roots of the most fatal aspect of cancer: how it metastasizes, or spreads, through the body.

Blood vessels act like highways for tumor cells to metastasize. Here, a tumor organoid (red) is growing near an artificial microvessel (green).

A Guggenheim for Greene

Johns Hopkins’ Jeremy Greene, a noted historian of how medical technology influences our understandings of sickness and health, has been awarded a Guggenheim Fellowship — one of 171 scientists, writers, scholars and artists selected for the prestigious honor from a pool of nearly 2,500 applicants.

Jeremy Greene

Highest Distinction

Five researchers from the Johns Hopkins University School of Medicine were elected as 2022 fellows of the American Association for the Advancement of Science — one of the highest distinctions in the global science community, which recognizes both achievements in science and scientific integrity. They join more than 500 researchers inducted into the 2022 class of fellows.

Rao and Robinson